Total planned funding: $1,766,309,602
Clear active filters
Nigeria
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $1,766,309,602 |
Organizational Types
NGO | $404,772,942 |
Private Contractor | $377,884,000 |
Unknown | $348,977,474 |
University | $232,547,503 |
Implementing Agency | $157,813,435 |
Own Agency | $132,943,127 |
FBO | $92,878,008 |
Other USG Agency | $9,766,033 |
Host Country Government Agency | $6,750,000 |
Multi-lateral Agency | $1,977,080 |
Program Areas
Treatment | $676,490,022 |
Care | $348,434,195 |
Prevention | $286,272,284 |
Governance and Systems | $279,570,464 |
Management and Operations | $104,739,180 |
Testing | $70,803,457 |
Budget Codes
HTXD: Treatment: ARV Drugs | $344,396,652 |
HTXS: Treatment: Adult Treatment | $311,086,023 |
HKID: Care: Orphans and Vulnerable Children | $144,529,945 |
HBHC: Care: Adult Care and Support | $137,868,146 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $134,163,385 |
HLAB: Laboratory Infrastructure | $127,852,027 |
HVMS: Management and Operations | $104,739,180 |
OHSS: Health Systems Strengthening | $93,190,452 |
HVCT: Testing: HIV Testing and Counseling | $70,803,457 |
HVOP: Sexual Prevention: Other Sexual Prevention | $60,703,060 |
HVSI: Strategic Information | $58,527,985 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $52,155,090 |
HVTB: Care: TB/HIV | $47,843,922 |
HMBL: Biomedical Prevention: Blood Safety | $24,009,986 |
PDTX: Treatment: Pediatric Treatment | $21,007,347 |
PDCS: Care: Pediatric Care and Support | $18,192,182 |
HMIN: Biomedical Prevention: Injection Safety | $15,240,763 |
Top Partner Programs
Not Available:
$287,472,407
Countries/Regions
FHI 360:
$179,886,881
Countries/Regions
Harvard University:
$116,478,028
Countries/Regions
USG Aggregated Agencies:
$97,604,405
Countries/Regions